Loading stock data…
AZTR
$0.25+0.00 (+0.45%)
Market ClosedLast close May 1
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Azitra, Inc. in the Healthcare sector is trading at $0.25. The stock is currently near its 52-week low of $0.10, remaining 51.5% below its 200-day moving average. Technical signals show overbought RSI of 83 and bullish MACD crossover, explaining why AZTR maintains its current current market pressure. The Whystock Score of 10/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 83) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.25
Potential Upside
5%
Whystock Fair Value$0.26
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.47M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-2.17
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-288.21%
Volume
Today's trading volume
317,866
Recent News
Wall Street Set to Open Higher Monday as Investors Look Ahead to a Week of Earnings Reports
US stocks look set to open higher in Monday's trading session ahead of a raft of earnings coming out
Why Is Azitra (AZTR) Stock Soaring Today
AZTR: Azitra Soars After First Patient Dosed in FDA Fast Track Trial
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Wednesday afternoon, with the NYSE Health Care Index adding 0.1%
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Health care stocks rose Wednesday afternoon with the NYSE Health Care Index adding 0.2% and the Heal